Search

everythinglearnresearchcommunity

for

Search:↓

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Early identification of lupus through skin signs and blood tests is crucial in India.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Chronic cutaneous lupus erythematosus should be considered when acne treatments don't work.

A woman with lupus experienced hair regrowth after treatment, but hair transplantation is not advised for her condition.

Damage to hair follicle stem cells causes permanent hair loss and scarring in cutaneous lupus erythematosus.

A patient with patchy hair loss was successfully treated for Tumid Lupus Erythematosus after other treatments failed.

Hair loss in lupus patients indicates higher disease activity.

A patient with both bullous lichen planus and systemic lupus erythematosus showed improvement with treatment.

Hydroxychloroquine is ineffective for treating frontal fibrosing alopecia with lupus erythematosus.

A woman's hair loss led to discovering she had lupus.

Early treatment and regular check-ups are crucial for lupus patients to prevent progression and improve outcomes.

Patients with cutaneous lupus are most concerned about self-consciousness, physical symptoms, and disease progression.

Lower GPX4 mRNA levels are linked to higher disease activity and symptoms in lupus patients.

Visual field defects in lupus nephritis can be caused by hypertensive retinopathy, not glaucoma or medication toxicity.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

Increased mucin in the skin might indicate lupus in patients with hair loss, but more research is needed.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

CLASI is a valid tool for assessing skin activity and damage in lupus patients.

The conclusion is that accurate diagnosis of different types of hair loss requires careful examination of tissue samples and understanding of clinical symptoms.

The document concludes that different types of hair loss have specific treatments, and early diagnosis is crucial for preventing permanent hair loss.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Pseudopelade of Brocq is hard to diagnose and treat, with limited effective options.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.